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Summary 
Translational control of gene expression plays a key role during early phases of 
embryonic development. Here we describe a novel regulator of mouse embryonic stem 
cells (mESCs), Yin-Yang 2 (YY2) that is controlled by the translation inhibitors, 4E-BPs. 
YY2 plays a critical role in regulating mESC functions through transcriptional control of 
key pluripotency factors, including Oct4 and Esrrb. Importantly, overexpression of YY2 
directs the differentiation of mESCs into cardiovascular lineages. We show that the 
splicing regulator PTBP1 promotes the retention of an intron in the 5´ UTR of Yy2 
mRNA, which confers sensitivity to 4E-BP-mediated translational suppression. Thus, we 
conclude that YY2 is a major regulator of mESC self-renewal and lineage commitment, 
and document a multilayer regulatory mechanism that controls its expression.  
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Statement of significance 
Stringently controlled mRNA translation is critical for embryonic stem cells (ESCs), 
which in contrast to differentiated cells, rely on low translation rate to maintain stemness 
by unknown mechanisms. By employing ribosome profiling to unveil the eIF4E-sensitive 
mRNAs in ESCs, we identified a hitherto not studied ESC-related transcription factor, 
YY2, which controls self-renewal and differentiation of ESCs. While a basal level of 
YY2 is essential for ESC self-renewal, increased YY2 expression directs differentiation 
of mESCs toward cardiovascular lineages. By comprehensive examination of the Yy2 
5’UTR, we delineated a novel, multilayer regulatory mechanism in mESCs by which 
YY2 expression is dictated by the combined actions of the splicing regulator, PTBP1, and 
the translation inhibitors, 4E-BPs. ChIP-Seq analysis revealed that YY2 directly controls 
the expression of several pluripotency and development-related genes. This is the first 
study that describes a synchronized network of alternative splicing, and mRNA 
translation in controlling self-renewal and differentiation. 
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Introduction 
Stringent control of mRNA translation is critical during early embryonic development, as 
relatively small changes in expression of developmentally related genes dramatically 
affect self-renewal and differentiation of stem cells. In fact, a  modest (≤ 2 fold) increase 
or decrease in OCT4 or SOX2 protein levels impairs ESC self-renewal and triggers 
differentiation (Kopp et al., 2008; Niwa et al., 2000). mRNA translation, which is low in 
undifferentiated ESCs and multipotent somatic stem cells (e.g. HSCs and skin stem cell), 
increases significantly during differentiation (Blanco et al., 2016; Sampath et al., 2008; 
Signer et al., 2014). Importantly, genome-wide analysis of the transcriptome vs. proteome 
of ESCs during early stages of differentiation demonstrated that protein levels do not 
correlate with mRNA levels (Pearson’s R<0.4), underscoring the importance of post-
transcriptional regulation in ESC differentiation (Lu et al., 2009).  
mRNA translation can be divided into three steps; initiation, elongation, and 
termination. Translational control has been documented most extensively at the initiation 
step, at which ribosomes are recruited to the mRNA by the concerted action of eukaryotic 
translation initiation factors (eIFs) (Sonenberg and Hinnebusch, 2009). Control of 
translation is exerted mainly by two key protein complexes: eIF4F (eIF4E-eIF4G-eIF4A) 
and the ternary complex (eIF2–GTP–Met-tRNAMeti) (Sonenberg and Hinnebusch, 2009). 
The mammalian target of rapamycin complex 1 (mTORC1) controls the assembly of 
eIF4F through phosphorylation of eIF4E-binding proteins (4E-BPs) (Beretta et al., 1996; 
Pelletier et al., 2015). The 4E-BPs consist of a family of small molecular weight 
translational inhibitors (15-20 kDa; 4E-BP1, 2 and 3 in mammals), that when 
dephosphorylated, avidly bind eIF4E and block its association with eIF4G to form the 
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eIF4F complex. Following phosphorylation by mTORC1, 4E-BPs dissociate from eIF4E, 
allowing eIF4F complex formation and activation of translation (Beretta et al., 1996; 
Brunn et al., 1997; Hara et al., 1997). 4E-BPs inhibit cap-dependent translation in 
embryonic and somatic stem cells (Hartman et al., 2013; Sampath et al., 2008; Signer et 
al., 2014). While eIF4E promotes cap-dependent translation of all cellular mRNAs, the 
translation of a subset of mRNAs, which generally contains long and highly structured 5´ 
untranslated region (5´ UTR), is strongly dependent on eIF4E (Koromilas et al., 1992; 
Pelletier et al., 2015). These mRNAs are known as “eIF4E-sensitive”, and encode 
proteins that control fundamental cellular processes, such as cell proliferation and 
survival (Bhat et al., 2015).  
We showed that 4E-BPs are required for reprogramming of mouse embryonic 
fibroblasts (MEFs) to induced pluripotent stem cells (iPSCs) (Tahmasebi et al., 2014). In 
the current study, we describe a tightly coordinated network in mESCs whereby the 
expression of YY2 transcription factor is controlled via the splicing regulator PTBP1 and 
the translation inhibitors, 4E-BPs. Our data reveal that tight regulation of YY2 expression 
by this network is critical for mESC self-renewal and lineage commitment. 
 
Results  
 
Transcriptome and translatome profiling of WT and 4E-BP1/2-null mESCs 
To investigate the role of 4E-BPs in mESCs, we first derived mESCs from wild-type 
(WT) and Eif4ebp1 and Eif4ebp2 double-knockout (DKO) mice and examined the eIF4F 
complex using m7GTP-agarose pull-down assay. eIF4F amount was elevated, as 
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demonstrated by increased (~14-fold) eIF4G1 pull-down in DKO mESCs (Figure S1A). 
However, polysome profiling (Figure S1B) and [35S]methionine/cysteine labeling assays 
(Figure S1C) did not detect a substantive difference in global mRNA translation between 
WT and DKO mESCs. These data are consistent with previous findings that the  lack of 
4E-BPs affects the translation of a subset of mRNAs, rather than global translation 
(Dowling et al., 2010; Tahmasebi et al., 2014).  
To identify 4E-BP-sensitive mRNAs in mESCs, we performed ribosome profiling 
(Ingolia et al., 2009), which allows for precise measurement of the translation of mRNAs 
on a genome-wide scale, by deep sequencing of ribosome-protected fragments (ribosome 
footprints; RFPs). We achieved a high degree of reproducibility between the replicates 
for mRNA-Seq and footprints (R2>0.97 Figure S1D). Metagene analysis confirmed the 
enrichment of RFP reads in coding sequences and the expected three-nucleotide 
periodicity (Figure S1E). These analyses validated the quality of the mRNA and RFP 
libraries (Supplemental Table 1). We used Babel analysis (Olshen et al., 2013) to 
compute changes in abundance of RFPs (Figure 1A), independent of changes in the levels 
of their corresponding mRNAs (Figure 1B). A significant enhancement in translation 
efficiency (TE) of a small subset of mRNAs was detected in DKO mESCs (FDR<0.1; 
Figure 1C and Supplemental Table 2), consistent with the lack of global change in 
translation in the DKO mESCs (Figure S1B and C). Strikingly, mRNA-Seq data revealed 
downregulation of mRNA levels for several pluripotency factors, such as Prdm14, Eras, 
Esrrb, and Nanog in DKO mESCs (Figure 1D and Supplemental Table 3). Possible 
reasons for this will be addressed in the Discussion. 
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Ablation of Eif4ebp1 and Eif4ebp2 results in  reduced expression of mESCs markers 
To validate the mRNA-Seq results, we examined the expression of pluripotency factors 
in undifferentiated WT and DKO mESCs, as well as after differentiation, by WB and RT-
qPCR. While all DKO mESC lines maintained normal morphology under standard mESC 
culture conditions (in the presence of LIF and feeder layer [irradiated MEFs]), expression 
of the ESC marker NANOG was markedly reduced (Figure 1E). These changes were not 
due to unintended consequences of the knockout procedure, as RNAi-mediated depletion 
of 4E-BP1 and 2 (DKD; double knockdown) resulted in a similar reduction in NANOG 
(Figure S2A). DKO mESCs proliferated slower than WT mESCs (Figure S2B), and when 
cultured in the absence of feeder layer, they exhibited flattened morphology, which is 
indicative of cellular differentiation, while WT mESCs preserved their normal 
morphology (Figure S2C). Similar morphological changes were observed in DKD ESCs 
(Figure S2D). Notably, when cultured in the absence of LIF and feeder layer, NANOG 
and OCT4 expression was dramatically suppressed in DKO mESCs, while WT mESCs 
maintained higher expression of these proteins (Figure S2E). In addition to Nanog, 
mRNA levels of Oct4 and Sox2 were lower in DKO mESCs on day-0 of differentiation 
(Figure S2F). Moreover, mRNA levels, as determined by RT-qPCR of several other 
ESC-related factors, such as Lin28a, Eras, and Tets (Tet1, 2 and 3), were reduced in 
DKO mESCs (Figure S2G). Therefore, 4E-BPs are required for normal expression of 
pluripotency factors. Analysis of embryoid bodies (EB) derived from WT and DKO 
ESCs revealed that the lack of 4E-BP1 and 4E-BP2 resulted in differentiation of mESCs 
toward mesodermal and endodermal lineages, as indicated by significant upregulation of 
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Bmp4, an early mesoderm marker, and Gata4 and Gata6, early endoderm markers 
(Figure S2H). This coincides with the downregulation of the neuroectoderm markers, 
Map2 and Sox17 mRNAs, in DKO EBs. 
The decrease in mRNA levels for several pluripotency factors, such as Nanog, Eras, and 
Esrrb, in 4E-BP DKO mESCs, as compared to WT mESCs (Figures 1D, S2F and S2G) 
(Supplemental Table 3), suggests that 4E-BP-dependent translational regulation of one or 
more factor(s) effects the changes in the transcriptome. 
  
Stringent control of YY2 expression in mESCs  
One of the mRNAs exhibiting the most significant increase in translation efficiency in 
DKO mESCs versus WT cells is the Yin-Yang 2 (Yy2) transcription factor (Babel p-value 
= 0.0001; Figure 1C and Supplemental Table 2). YY2 exhibits considerable sequence 
homology (55% identity) with the YY1 transcription factor (Nguyen et al., 2004). Similar 
to Rex1 (Zfp42), a well-known ESC marker (Kim et al., 2007; Rogers et al., 1991), YY2 
is a retroposed copy of the YY1 gene, which evolved only in placental mammals (Luo et 
al., 2006). YY1 is a pleiotropic transcription factor that regulates diverse cellular 
processes and plays a critical role in early embryonic development, ESC biology, and 
reprogramming (Donohoe et al., 1999; Onder et al., 2012; Vella et al., 2012). Although 
their N-terminal domains differ significantly, the C-terminal DNA binding domain of 
YY1 is highly conserved in Rex1 and YY2 (Kim et al., 2007). This raises the possibility 
that YY2 plays an important role in regulation of gene expression in mESCs. While there 
is no significant change in the level of Yy2 mRNA in DKO mESCs as compared to WT 
cells (Figure S3A), YY2 protein, but not YY1, is elevated in DKO mESCs (Figure 1F). 
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Importantly, expression of a phosphorylation-resistant 4E-BP1-4A mutant (Thoreen et 
al., 2012) in DKO mESCs reduced YY2 protein levels (Figure 1G). These data 
demonstrate that the translation of Yy2 mRNA is controlled by 4E-BPs. 
To further study the functional consequence of YY2 upregulation in mESCs, we 
generated a mESC line carrying a doxycycline-inducible YY2 construct (dox-YY2). 
Consistent with the DKO mESC data (Figure 1D and S2E-G), overexpression of YY2 
caused a reduction in expression of pluripotency factors, Nanog, c-Myc, and Oct4 
mRNAs (Figure 2A and B), indicating a negative role for YY2 in mESC self-renewal. 
However, constitutively expressed shRNA against Yy2 in mESCs caused a dramatic 
depletion of mESCs in culture (Figure S3B). This coincided with increased levels (8.4 ± 
2.4 fold) of the apoptosis marker, cleaved Caspase-3, in Yy2 knockdown cells (Figure 
S3C) suggesting that mESCs require a basal level of YY2 expression for survival. To 
study the impact of a moderate knockdown, we generated an mESC line carrying 
doxycycline-inducible shRNA construct against Yy2 (shYy2). While slight induction of 
shYy2 (0.2 g/ml doxycycline) enhanced expression of the pluripotency factors Nanog 
and Sox2 (Figure 2C), higher doses of doxycycline failed to do so (Figure 2C), indicating 
a dose-sensitive effect of YY2 on mESC pluripotency. Importantly, the deleterious effect 
of complete depletion of YY2 was not limited to mESCs, as CRISPR/Cas9-mediated Yy2 
knockout blastocysts were unable to maintain their inner cell mass, as demonstrated by 
blastocyst outgrowth assays (Figures 2D, S3D and E). A similar defective outgrowth has 
been previously described for Yy1-/- blastocysts (Donohoe et al., 2007), suggesting that 
lack of YY2 may cause peri-implantation lethality and demonstrating that YY1 and YY2 
fulfill non-redundant functions in blastocysts growth. 
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Recent studies showed that YY1 directly regulates Nkx2.5 expression and 
promote cardiogenesis uncovered a novel function for YY1 in cardiomyocyte 
differentiation and cardiac morphogenesis (Beketaev et al., 2015; Gregoire et al., 2013). 
To examine the effect of YY2 on mESC differentiation toward cardiovascular lineages, 
embryoid bodies (EBs) derived from dox-YY2 ESCs were exposed to doxycycline. One 
week after induction of YY2 expression, foci of beating cardiomyocytes began to appear 
in the plates with the highest level of YY2 induction (0.2 g/ml doxycycline) 
(Supplemental Video 1), and the number of foci continued to increase in the following 2 
weeks. No beating foci appeared in non-induced embryoid bodies up to the 3rd week of 
differentiation. Consistently, expression of several cardiovascular-specific markers, such 
as: Nkx2.5, Bnp, MHC, MLC2 and MLC2v mRNAs was increased in the YY2-
overexpressing embryoid bodies in a dose-dependent manner (Figure 2E). These data 
suggest that YY1 and YY2 have overlapping function in directing differentiation of 
mESC toward cardiovascular lineages. 
 
YY2 binds to regulatory regions of key genes for ESC pluripotency and 
differentiation 
Genomic targets of YY1, but not YY2, in mESCs have been documented (Sigova et al., 
2015; Vella et al., 2012). We determined the genome-wide binding sites of YY2 in 
mESCs by ChIP-Seq in cells overexpressing YY2. Due to the high degree of similarity 
between the C-terminal domains of YY1 and YY2, we used a monoclonal antibody that 
specifically recognizes the N-terminal domain of YY2 (Figures 2A and S3F, see 
Supplementary Materials and Methods). YY2 binding sites (Supplemental Table 4) 
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exhibit enrichment for the genomic loci of coding genes (exons or introns, symbolized by 
Gene, 43%; Figure 3A) and a preference for the promoter regions surrounding the 
transcription start sites (Figure 3B). Nearly half of the peaks contained the consensus 
YY1-binding motif (Figure 3C), which is consistent with similar sequence preference for 
YY1 and YY2 (Kim et al., 2007; Nguyen et al., 2004). Motif distribution across binding 
peaks revealed enrichment for the known consensus YY1 binding motif directly at YY2 
peak centers (Figure 3D), indicating specific recognition of these binding sites by YY2.  
Pathway analysis of genes associated with YY2 binding peaks by Ingenuity 
Pathway Analysis program (IPA) revealed significant enrichment for genes related to 
embryonic stem cell pluripotency (Figure 3E), such as Oct4, Tdgf1, Esrrb, and FoxD3. 
We also found enrichment for genes involved in the activation of the retinoic acid 
receptor (RAR)-signaling pathway. Previous studies showed that activation of the RAR 
pathway promotes differentiation of ESC to cardiomyocytes, particularly MLC2v+ 
ventricular cardiomyocytes, and that the RAR-signaling pathway plays a critical role in 
cardiogenesis (Pan and Baker, 2007; Wobus et al., 1997). These findings indicate that 
activation of this pathway, along with other cardiovascular-related YY2 targets (e.g. Bnp, 
Mesp2 and Mkl1), is responsible for engendering differentiation of mESCs toward 
cardiovascular lineage by YY2 (Figure 2E). We validated the ChIP-Seq results for a 
selected number of genes with ChIP-qPCR (Figures 3F, 3G and S3G).  
RT-qPCR analysis of a selected number of pluripotency factors in the ChIP-Seq 
dataset, such as: Oct4, Esrrb, Tet1, and Tet2 mRNAs, revealed that YY2 overexpression 
suppresses their expression in mESCs (Figure 4A). The ChIP-Seq analysis did not 
identify Nanog as a target of YY2. Thus, the decrease in Nanog mRNA expression in 
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DKO mESC (Figure 1D and E) or upon overexpression of YY2 (Figure 2A and B) is 
likely secondary to downregulation of other pluripotency factors. In agreement with our 
previous observation (Figure 2C), doxycycline-inducible Yy2 knockdown in mESCs 
revealed a dose-sensitive regulation of its target genes (Figure 4B). 
We analyzed the target genes identified by the YY2 ChIP-Seq assay relative to 
those of YY1 in mESCs (Sigova et al., 2015). 27.8% of YY2 targets are shared with YY1 
(Figure 4C and Supplementary Table 4). Conversly, a large portion of the YY2 targets 
(~72%) are not present among the YY1 targets (Figure 4C), which supports a previous 
genome-wide mRNA expression study in HeLa cells that demonstrated that YY1 and 
YY2 regulate some shared, but  mostly unique sets of genes (Chen et al., 2010). While 
some pluripotency-related genes, such as Tdgf1, are unique YY2 targets, Oct4, Klf5, and 
Foxd3 are common targets between YY1 and YY2 (Figure 4C). Notably, Yy1 is a target 
of both YY1 and YY2 and our data showed that YY2 has a dose-sensitive effect on YY1 
expression (Figure 2A and C). The similar consensus-binding motifs of YY1 and YY2 
are consistent with these factors exhibiting overlapping or competing effects on common 
target genes (Klar, 2010; Klar and Bode, 2005; Lee et al., 2015; Nguyen et al., 2004). 
One plausible explanation for their distinct activities is the considerable divergence in 
their N-terminal domains (Figure S4A). A recent report showed that binding of YY1 to 
active promoters/enhancers in ESCs through its C-terminal DNA-binding domain is 
facilitated by simultaneous binding of its N-terminal domain to RNA species transcribed 
from these regulatory elements (Sigova et al., 2015). We hypothesized that the N-
terminal domain of YY2 cannot interact with RNA. We examined this possibility by 
Electrophoretic Mobility Shift Assay (EMSA) using purified mouse YY1 and YY2 
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proteins (Figure S4B and C), and DNA and RNA probes derived from the ARID1A 
promoter, which interact with YY1 (Sigova et al., 2015). Notably, Arid1a is among the 
YY2 targets in our ChIP-Seq analysis (Supplemental Table 4). While YY2 interacts with 
the DNA probe with only slightly less efficiency than YY1 (Figure 4D), only YY1 binds 
to the RNA probe (Figure 4E), as no visible binding was detected for YY2 to the Arid1a 
promoter-derived RNA, even after prolonged exposure (Figure S4D). In agreement with 
these results, analysis of the N-terminal domains of mouse YY1 and YY2 proteins by 
BindN, an RNA-binding prediction server (Wang and Brown, 2006), identified two 
distinct RNA-binding motifs for YY1, which are not conserved in YY2 (Figure S4E). 
Our data suggest a novel mechanism by which YY2 may act differently from YY1, 
whereby differential affinity for the promoter-derived RNAs may underlie the opposing 
effects of YY1 and YY2 on certain shared promoters. 
 
A retained 5´ UTR intron renders Yy2 mRNA sensitive to 4E-BP-dependent 
translational repression 
To search for eIF4E-sensitive elements in the 5´ UTR of Yy2 mRNA, we first used 5′ 
RACE (5´-rapid amplification of cDNA ends) to annotate the sequence in mESCs. In 
addition to the annotated mRNA sequence of 217 nt 5´ UTR (RefSeq: 
NM_001098723.1), henceforth referred to as variant A, we uncovered two additional 
variants, possessing 290 nt and 100 nt long 5´ UTRs (Figure 5A and B). While the 290 nt 
variant, designated as variant B, is a 5’ extension of variant A, the 100 nt variant is a 
spliced version of variant A, lacking 117 nt. The spliced region harbors all of the features 
of a canonical intron, including a GU dinucleotide at the 5´ splice site (SS), AG 
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dinucleotide at the 3´ SS, and a polypyrimidine tract and putative branch site A 
nucleotide within 20 nucleotides of the 3´ SS (Figure 5A). Considering that the intronic 
sequence is shared between variants A and B, we termed their corresponding spliced 
variants ΔA and ΔB, respectively (Figure 5B). Retroposed genes are generally intronless, 
as they are generated through the reverse transcription of mature mRNAs (Fablet et al., 
2009; Vinckenbosch et al., 2006). Therefore, the intron acquisition by Yy2 is most likely 
a recent evolutionary event that occurred after the retroposition of Yy2 from Yy1 in 
placental mammals. 
To measure intron retention (IR) in Yy2 mRNA during differentiation of mESC by 
RT-PCR, we used two forward (Fw1 and Fw2) primers and a common reverse primer 
(Rv) to target the flanking exons (Supplemental Table 6). Primers Fw1 and Rv only 
detect variants B and ΔB (297 bp and 180 bp PCR products, respectively), whereas Fw2 
and Rv amplify a 209 bp PCR product for variants A and B, and a 92 bp PCR product for 
variants ΔA and ΔB. We examined Yy2 IR events in mESCs and EBs at day 4 and 6 
post-differentiation and measured the degree of IR using the metric of percent intron 
retention (PIR) (Braunschweig et al., 2014). There is a higher percentage of non-spliced 
variants (A and B) in mESCs than in EBs, demonstrating that differentiation coincided 
with a marked reduction in intron retention (Figures 5C and S5A). Notably, this 
alternative splicing event is not restricted to mESCs, as various degrees of intron 
retention were detected at different embryonic stages and across different tissues (Figures 
5D and S5B), demonstrating developmental and tissue-specific regulation of Yy2 
alternative splicing.  
To identify the trans-acting factor(s) responsible for Yy2 alternative splicing, we 
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used the RBPmap web server to predict consensus motifs for RNA-binding proteins (Paz 
et al., 2014). We identified two canonical PTBP (polypyrimidine tract-binding protein) 
recognition motifs (CUCUCU) flanking the Yy2 5´ UTR intron (Figures 5A, 5B and 
S5C). PTBP1 and PTBP2 (a neural and testis enriched paralog) are RNA-binding 
proteins implicated in several aspects of mRNA metabolism, including: alternative 
splicing, stability, localization, and polyadenylation (Oberstrass et al., 2005). PTBP1 is 
essential for embryonic growth before gastrulation, as Ptbp1-/- mESCs have severe 
proliferation defects (Shibayama et al., 2009; Suckale et al., 2011). To explore its role in 
Yy2 5´ UTR intron retention, PTBP1 was depleted in mESCs using shRNA (Figure S5D). 
PTBP1 knockdown resulted in reduced Yy2 intron retention, demonstrating that it acts as 
an inhibitor of Yy2 splicing in mESCs (Figure 5E). This was associated with reduced 
growth and smaller colonies of mESCs (Figure S5E). To demonstrate that PTBP1 
directly affects Yy2 5´ UTR splicing, we employed an in vitro splicing assay using a 
WERI retinoblastoma (WERI-Rb) cell extract, purified recombinant PTBP1 protein, and 
the three Yy2 5´ UTR variants (A, B and ΔA). Incubation with cell extract resulted in 
splicing of the introns from A and B variants, with no effect on the ΔA variant (Figure 
S5F and G). Importantly, addition of recombinant PTBP1 protein (Figure S5H) 
dramatically suppressed splicing and resulted in the complete retention of the intron in a 
dose-dependent manner (Figures 5F and S5I).  
The length and complexity of the 5´ UTR play a critical role in mRNA 
translation, as mRNAs with long and structured 5´ UTRs are more sensitive to eIF4E 
activity (Colina et al., 2008; Koromilas et al., 1992). The combined use of alternative 
transcription start sites and alternative splicing determine the complexity of the Yy2 5´ 
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UTR. To examine the effect of 5´ UTR variants on mRNA translation, we constructed 
luciferase reporters containing the 5´ UTRs of the A, B and ΔA variants (Figure S5J), 
which were used to generate mRNAs that were transfected into WT and DKO mESCs. 
The B, and to a lesser extent A, variant mRNAs were poorly translated, while the intron-
less ΔA variant translation was dramatically better  (>6 compared with control) in WT 
mESCs (Figure 5G, left panel). These data demonstrate that the 5´ UTR containing the 
optional intron sequence inhibits translation. The translation of A and B variant mRNAs 
was significantly elevated in the DKO mESCs, whereas the ΔA variant remained 
insensitive to 4E-BPs levels (Figure 5G, right panel). These results demonstrate that 
intron retention in Yy2 5´ UTR, in combination with 4E-BPs activity, determine the 
outcome of Yy2 mRNA translation. Intron retention adds an extra 117 nt to the Yy2 5´ 
UTR, which increases its secondary structure complexity (Figure S5K), rendering it 
sensitive to 4E-BP-mediated translation repression. This double-layered control 
mechanism, consisting of the retention of the Yy2 5´ UTR intron by PTBP1 and 
suppression of translation of the resulting mRNA variant by 4E-BPs, allows for the 
adjustment of Yy2 mRNA translation. 
Consistent with the increased translation of the Yy2 spliced variant (Figure 5G), 
the highest expression of YY2 protein was detected in the heart and muscle (Figure S5L) 
tissues, in which the lowest degree of Yy2 5´ UTR intron retention is observed (Figure 5D 
and S5B).  
 
Discussion 
Many mammalian mRNAs species contain heterogeneous 5’UTRs (Mele et al., 
2015). Length, structure, and sequence elements in the 5’UTRs strongly impact 
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translation (de Klerk and t Hoen, 2015; Floor and Doudna, 2016). We found that the 
combination of alternative transcription start sites and splicing produces four Yy2 mRNA 
variants with different translation efficiencies. Thus, the relative level of each variant, in 
combination with 4E-BP activity, dictates the rate of YY2 protein synthesis. ESC 
differentiation, which is concomitant with downregulation of PTBP1 expression (Linares 
et al., 2015), triggers the splicing of the Yy2 5´ UTR intron. However, there is 
considerable variation in the rate of Yy2 5´ UTR intron retention (IR) among adult mouse 
tissues, with heart and skeletal muscle displaying the lowest rate of IR. Different degrees 
of IR among mouse tissues, most of which express very low levels of PTBP1 (Figure S6), 
implies the existence of additional regulatory mechanism(s) that augments splicing of the 
Yy2 5´ UTR intron in heart and skeletal muscles. We also found consensus binding motifs 
for the MBNL1 splicing factor in the Yy2 5’UTR (Figure S5C). MBNL1 is highly 
expressed in cardiac and skeletal muscles (Miller et al., 2000) and is a known regulator of 
mRNA splicing in these tissues (Han et al., 2013; Kino et al., 2009). IR has emerged as a 
widespread mechanism to regulate gene expression in different cell and tissue types as 
well as during stem cell differentiation (Braunschweig et al., 2014). The finding that a 
retained intron at the 5´ UTR of Yy2 mRNA controls its translation underscores the 
intricate interplay between alternative splicing and translational control (Maslon et al., 
2014; Sterne-Weiler et al., 2013).  
We established Yy2 mRNA as a target of 4E-BP-dependent translation 
suppression in mESCs, and demonstrated that a basal level of YY2 expression is essential 
for mESC survival. Similar to Yy1 knockout embryos, CRISPR-mediated Yy2 knockout 
embryos survived the pre-implantation period, but the growth of their inner cell mass was 
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impaired, as revealed by blastocyst outgrowth assays (Figure 2D). These observations 
exclude the possibility of redundant functions for YY1 and YY2 in early stages of 
embryonic development. The critical function of YY2 in mESCs is most likely mediated 
by its direct transcriptional regulation of ESC-related genes, such as Oct4,  Eras, Tet1, 
Tet2, and Tdgf1. We demonstrated that mESCs are highly sensitive to YY2, and a modest 
manipulation of Yy2 amount significantly affects expression of pluripotency factors, ESC 
self-renewal, and differentiation (Figures 2A-C and 4A-B).  
We documented that increased expression of YY2 directs differentiation of mouse 
embryoid bodies (mEBs) toward the cardiovascular lineage. The importance of YY2 in 
cardiomyocytes is likely not limited to early differentiation, as the heart expresses the 
highest level of YY2, as compared to other tissues of adult mouse (Figure S5L). This 
function is likely mediated by transcriptional control of the RAR pathway and multiple 
mesoderm/cardiomyocyte-related YY2 targets, such as Bmp4, Nodal, Bnp, Mesp2, and 
Mkl1, as evident by the ChIP-Seq analysis. Recent studies showed binding of YY1 to the 
promoters of highly expressed ribosomal proteins and the nuclear encoded mitochondrial 
membrane, enzymes, and ribosomal proteins (Chen et al., 2010), and highlighted the 
importance of YY1 in cardiomyocyte differentiation and heart morphogenesis (Beketaev 
et al., 2015; Gregoire et al., 2013). Notably, cardiac specific ablation of Yy1 causes 
severe abnormalities in the heart indicating that YY2 in the heart does not compensate for 
YY1 deletion (Xi et al., 2007). Comparison of YY2 and YY1 ChIP-Seq data (Figure 4C 
and Supplementary Table 4) demonstrated overlapping sets of nuclear encoded 
mitochondrial proteins, such as aminoacyl tRNA synthetase Tars2, and Lars2 as well as 
mitochondrial ribosomal proteins Mrps18c, Mrpl1, Mrpl44 and Mrpl53 (Figure 4C and 
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Supplementary Table 4). Existence of unique as well as overlapping target genes among 
YY2 and YY1 targets explains the convergent, yet non-redundant, function of YY1 and 
YY2 in development. 
In summary, we described a novel mechanism by which mESC self-renewal and 
lineage commitment is controlled via stringent regulation of YY2 expression at two 
stages; a, by repressing the splicing of the Yy2 5´ UTR intron via Ptbp1, and b, through 
suppressing the translation of the resulting mRNA variant by of Eif4ebp1 and 2. These 
two layers of control (Figure 6) coalesce to limit the expression of YY2 protein to a low 
basal level in mESCs, thereby maintaining their self-renewal and pluripotency.  
 
Materials and Methods 
ESC Cell Culture and differentiation 
Mouse ESCs were maintained in Dulbecco’s modified Eagle’s medium (DMEM, Wisent 
Inc.), 1% nonessential amino acids (Gibco), 1% L-Glutamine (Wisent Inc.), 1% sodium 
pyruvate (100× stock from Invitrogen), 0.1 mM β-mercaptoethanol, 15% fetal bovine 
serum, 1,000 U mouse LIF/ml (ESGRO, Millipore), penicillin (50 μg/ml), and 
streptomycin (50 μg/ml) and expanded on the feeder layer or gelatin. For mESC 
differentiation (Wobus et al., 2002), 800-2000 mESCs were cultured for 2 days in 
hanging drops containing differentiation medium [DMEM, 20% fetal bovine serum, 1% 
nonessential amino acids (Gibco), 1% L-Glutamine (Wisent Inc.), penicillin (50 μg/ml) 
and streptomycin (50 μg/ml). The resulting embryoid bodies were transferred to 
bacteriological dishes and cultured in suspension for an additional 3 days. Next, they 
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were platted onto gelatin-coated tissue cultured plates for the rest of the differentiation 
process. 
sgRNA synthesis  
The DNA template for Yy2 sgRNA was synthesized by PCR reactions using px330 
(Addgene) as a template. Two primers were used: T7-Yy2-sgRNA forward (5’-
TTAATACGACTCACTATAGGTTCGATGGTTTGGCCTACGCGTTTTAGAGCTAG
AAATAGC-3’) and sgRNA reverse (5’- AAAAGCACCGACTCGGTGCC -3’).  The 
PCR product was purified with the PCR DNA fragments extraction kit (Geneaid), and 
was used as a template for sgRNA synthesis with the T7 MAXIscript kit (Ambion).  The 
synthesized sgRNA was EtOH precipitated and dissolved in RNase free water. 
 
Cytoplasmic microinjection, embryo culture and blastocyst outgrowth 
50ng/µl Cas9 mRNA (Sigma) and 50ng/µl Yy2-sgRNA in 10 mM KCl was injected into 
CD1 zygotes in M2 media (Zenith Biotech). Cytoplasmic injection was performed with 
Femtojet (Eppendorf) and Cyto721 intracellular amplifier (WPI) for the Tickler’s 
oscillation to penetrate the zygote’s membrane. The injected zygotes were cultured for 4 
days in KSOM drops covered with mineral oil (Zenith Biotech) in a 5% CO2 incubator at 
37OC.  The zona pellucidae of the developed blastocysts were removed with acid-tyrode’s 
solution (Millipore). The blastocysts were plated on gelatin-coated 24-well plates and 
cultured 5-7 days in DMEM (Wisent) with ES-FBS (Wisent).   
Cycloheximide treatment and hypotonic cell lysis 
 22 
Cells were pretreated with cycloheximide (Bioshop Canada Cat#CYC003) (100 µg/ml) 
for 5 min, and lysed in hypotonic buffer; 5 mM Tris-HCl (pH 7.5), 2.5 mM MgCl2, 1.5 
mM KCl, 1x protease inhibitor cocktail (EDTA-free), 100µg/ml cycloheximide, 2 mM 
DTT, 200 U/ml RNaseIn), 0.5% (v/w) Triton X-100, and 0.5% (v/w) Sodium 
Deoxycholate, to isolate the polysomes. 
 
Polysome fractionation 
250 µg of the polysomes were separated on a 10%–50% sucrose gradient by 
ultracentrifugation at 36,000 RPM for 2 h in an SW40 rotor (Beckman Coulter) at 4°C, 
and fractionated using an ISCO gradient fractionation system and optical density at 254 
nm was continuously recorded with a FOXO JR Fractionator (Teledyne ISCO). 
 
Collection of ribosome footprints (RFPs) 
Ribosome profiling assay was performed as described  (Ingolia et al., 2012), with minor 
modifications. Briefly, 500 µg of the RNPs (2 biological replicates) were subjected to 
ribosome footprinting by RNase I treatment at 4oC for 50 min with gentle mixing. 
Monosomes were pelleted by ultracentrifugation in a 34% sucrose cushion at 70,000 
RPM for 3h and RNA fragments were extracted twice with acid phenol, once with 
chloroform, and precipitated with isopropanol in the presence of NaOAc and GlycoBlue. 
Purified RNA was resolved on a denaturing 15% polyacrylamide urea gel and the section 
corresponding to 28-32 nucleotides containing the RFPs was excised, eluted, and 
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precipitated by isopropanol. 
 
Random RNA fragmentation and mRNA-Seq 
150 µg of cytoplasmic RNA was used for mRNA-Seq analysis. Poly (A)+ mRNAs were 
purified using magnetic oligo-dT DynaBeads (Invitrogen) according to the 
manufacturer’s instructions. Purified RNA was eluted from the beads and mixed with an 
equal volume of 2X alkaline fragmentation solution (2 mM EDTA, 10 mM Na2CO3, 90 
mM NaHCO3, pH 9.2) and incubated for 20 min at 95oC. Fragmentation reactions were 
mixed with stop/precipitation solution (300 mM NaOAc pH 5.5 and GlycoBlue), 
followed by isopropanol precipitation. Fragmented mRNA was size-selected on a 
denaturing 10% polyacrylamide urea gel and the area corresponding to 35-50 nucleotides 
was excised, eluted, and precipitated with isopropanol. 
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Figure Legends 
 
Figure 1. Lack of 4E-BPs deregulates expression of pluripotency factors in mESCs. 
Log2 abundance of (A) ribosome footprints (RFP) and (B) mRNA abundance (RNA-
Seq) is plotted for wild-type (WT) and Eif4ebp1 and Eif4ebp2 double-knockout (DKO) 
mESCs. (C) Babel analysis of transcripts with significant change in ribosome footprints 
independent of the corresponding change in mRNA abundance (black dots; FDR<0.1). 
Triml2 and Trmt61b, respectively, are mRNAs with the highest and the lowest RFP ratio 
in DKO as compared to WT mESCs. (D) Heat-map representation of log2 mRNA 
expression levels of selected pluripotency factors in DKO over WT mESCs, identified by 
mRNA-Seq analysis. (E) Western blot analysis of NANOG expression in a WT and two 
independent DKO mESC clones (1 and 2). Numbers indicate the ratio of NANOG 
expression in each DKO clone compared with WT after normalization with ß-actin. (F) 
WB analysis of YY2 and YY1 expression in a WT and two independent DKO mESC 
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clones. Numbers indicate the ratio of NANOG expression in each DKO clone compared 
with WT after normalization with α-tubulin. (G) DKO mESCs carrying doxycycline-
inducible 4E-BP1-4A mutant construct were treated with 0, 0.005, 0.01, 0.05, 0.1 or 0.2 
g/ml doxycycline for 24 h and subjected to WB analysis. 
 
Figure 2. Stringent regulation of YY2 levels is critical for mESC survival and 
differentiation. (A) WB and (B) RT-PCR analysis of WT mESCs carrying doxycycline-
inducible YY2 construct and treated with 0, 0.2, 1 or 4 g/ml doxycycline for 24 h. (C) 
RT-qPCR analysis of Yy2 and pluripotency factors expression in mESCs transduced with 
a doxycycline-inducible shYy2 lentivirus. Resistant colonies were selected with 
puromycin (5 g/ml) and incubated with increasing amount of doxycycline (0, 0.2, 1 and 
4 µg/ml per day) for 72 h. Values are normalized to ß-actin. Data are mean ± s.d. (n=3). 
∗ p < 0.05, ∗ ∗ p < 0.01, ∗ ∗ ∗ p < 0.001, ns= non-significant. (D) Blastocyst-outgrowth assay 
in a WT and 2 independent CRISPR/CAS9-mediated Yy2 knockout embryos. Cas9 
mRNA and sgRNAs targeting Yy2 were injected into zygotes. The blastocysts derived 
from injected embryos were subjected to blastocyst-outgrowth assay. The mutagenesis 
strategy and the sequence of mutant alleles are provided in figure S3D and E. (E) RT-
PCR analysis of embryoid bodies carrying doxycycline-inducible YY2 construct, treated 
with 0, 0.002, 0.02 or 0.2 g/ml doxycycline every other day for 4 weeks.  
 
Figure 3. YY2 controls ESC transcriptional regulatory network and 
developmentally related genes. (A) Pie-chart displaying the distribution of YY2 ChIP-
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Seq peaks across the genome based on the distance of the peaks to the nearest RefSeq 
gene: Proximal (<2 kb upstream of Transcription Start Site; TSS), Gene (exon or intron), 
Distal (2 - 10 kb upstream of TSS), 5 d (10 - 100 kb upstream of TSS), Gene desert (>100 
kb from a RefSeq gene) and Other (anything not included in the above categories). (B) 
Histogram depicting the distance of YY2 ChIP-Seq peaks relative to the TSS of the 
nearest gene. (C) De novo motifs enriched in YY2-binding events. Enrichment p-values 
and percentage of targets containing each motif are displayed, as generated by HOMER 
software. (D) Plots showing average density of selected motifs in a 2 kb window from 
YY2 peak center. (E) Most significantly enriched canonical pathways in genes associated 
with YY2 ChIP-Seq peaks, as identified by Ingenuity Pathway Analysis. (F) Standard 
ChIP-qPCR validation of YY2 binding regions. Data are normalized to IgG. Lmnb2 gene 
was used as a negative control. (G) Graphical representation of selected YY2 binding 
peaks, obtained from the UCSC browser. 20 kb windows are displayed. 
 
Figure 4. Regulatory network and distinct mode of action of YY2 compared with 
YY1. (A) RT-qPCR analysis of selected YY2 targets in control and YY2-overexpressing 
mESCs. mESCs carrying doxycycline-inducible YY2 construct treated with 0 or 0.2 
g/ml doxycycline for 24 h. Values are normalized to ß-actin. Data are mean ± s.d. 
(n=3). ∗ ∗ p < 0.01, ∗ ∗ ∗ p < 0.001, ns= non-significant. (B) RT-qPCR analysis of YY2 
targets in mESCs transduced with a doxycycline-inducible shYy2 lentivirus as described 
in Figure 2C. Values are normalized to ß-actin. Data are mean ± s.d. (n=3). ∗ p < 0.05, 
∗ ∗ p < 0.01, ∗ ∗ ∗ p < 0.001, ns= non-significant. (C) Comparison of YY2 and YY1 ChIP-
Seq targets in mESCs. Only peaks with at least 1 nt overlap were considered as common 
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targets. (D) Electrophoretic mobility shift assay (EMSA) with radioactive labeled double-
stranded DNA oligonucleotide probe derived from the promoter region of the mouse 
Arid1a gene (Sigova et. al. 2015) and purified recombinant mouse 3xF-YY1 and 3xF-
YY2 proteins. The probes were incubated in the presence of increasing amounts of 
recombinant proteins in the presence or absence of antibodies as indicated. (E) EMSA 
with radioactive labeled single-stranded RNA oligonucleotide probe derived from the 
promoter region of the mouse Arid1a gene (Sigova et. al. 2015) and purified recombinant 
mouse 3xF-YY1 and 3xF-YY2 proteins.  
 
Figure 5. Retention of Yy2 5’UTR intron renders it sensitive to 4E-BP-mediated 
translation suppression. (A) Sequence of the promoter region of mouse Yy2 gene. The 2 
alternative transcription start sites (TSS) are marked by arrowheads, the boxed sequence 
shows the retained intron, the two highlighted hexamers are the consensus PTBP-binding 
motifs, and the underlined ATG is the translation start codon for Yy2 mRNA. (B) A 
cartoon depicting the 4 variants of Yy2 5’UTR. vB and vB represent long variant with 
and without intron retention, respectively; vA and vA represent short variant with and 
without intron retention, respectively. CD: Coding DNA sequence (C) RT–PCR using 
primer pairs designed to recognize all 4 possible variants (Fw2 and Rv) to estimate the 
splicing efficiency of the 5’ UTR intron in mESC and mouse embryoid body (mEB) in 
days 4 and 6 post-differentiation. (PIR: Percentage of Intron Retention). Gapdh mRNA 
was used as control. (D) RT-PCR analysis of intron retention (IR) in Yy2 5’UTR in 
different mouse embryonic stages and adult tissues using primers described in C. Gapdh 
mRNA was used as control. (E) RT-PCR analysis of IR in Yy2 5’UTR using primers 
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described in C upon depletion of PTBP1 expression in mESCs by two independent 
shRNAs. Yy2-ORF primers amplifying a segment of the coding region of Yy2 transcript 
were used to demonstrate the change in overall expression of Yy2 mRNA. -actin mRNA 
was used as internal control, (F) RT-PCR amplification (primers Fw2 and Rv) of the in 
vitro splicing products of the A, B and ΔA variants in WERI retinoblastoma cell extracts 
with different amounts of recombinant PTBP1 protein. Recombinant BSA was used as a 
negative control. (G) Luciferase reporter assay with Firefly (Fluc) and Renilla (Rluc) 
luciferase reporter mRNAs, as described in Fig. S5J. The in vitro-transcribed mRNAs 
were purified and transfected into WT and DKO mESCs. The left panel depicts the 
normalized luciferase activity of each construct in WT mESCs. The right panel compares 
the luciferase activity of each construct in DKO versus WT mESCs. Fluc mRNA was co-
transfected with Rluc mRNA as a transfection control. Data are mean ± s.d. (n=3). ∗ ∗ p < 
0.01, ∗ ∗ ∗ p < 0.001, ns= non-significant.  
 
Figure 6. Regulation of YY2 expression by splicing and mRNA translational control. 
Proposed model depicting the regulation of YY2 expression at two different steps: 1-
alternative splicing (via PTBP1) and 2-mRNA translation (via 4E-BP1/2). Basal level of 
YY2 expression is required for maintenance of mESC self-renewal, whereas increased 
translation of Yy2 mRNA directs cardiovascular lineage commitment. 
 
Supplementary Figure Legends 
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Supplementary Figure 1. Translation control in WT and 4E-BP1/2-null mESCs. (A) 
Lysates from WT and Eif4ebp1 and Eif4ebp2 double-knockout (DKO) mESCs were 
subjected to m7GTP pull-downs and analyzed for indicated proteins. (B) Polysome 
profiles of WT and DKO mESCs treated with 100 µg/ml cycloheximide for 5 min. 
Absorbance light was set at 254 nm. (C) [35S] methionine/cysteine incorporation into 
newly synthesized proteins from WT and DKO mESCs grown in 10% dialyzed fetal 
bovine serum and pulsed for 30 minutes with [35S] methionine/cysteine. Data are mean ±  
s.d. (n=3). (D) Correlation between replicates in mRNA-Seq and ribosome profiling 
datasets. R2 indicates Pearson correlation. (E) Metagene analysis of randomly fragmented 
mRNAs and ribosome footprints (RFPs) in mESCs. Normalized read counts are averaged 
across the entire transcriptome and aligned at the annotated start codons and stop codons.  
 
Supplementary Figure 2. Characterization of 4E-BP1/2-null mESCs. (A) Western 
blot analysis of mESCs transduced by lentivirus expressing shRNAs for 4E-BP1 and 4E-
BP2 (sh4EBP1/2) or control (shCTR). SE: short exposure, LE: long exposure. (B) Cell 
growth assay for WT and Eif4ebp1 and Eif4ebp2 double-knockout (DKO) mESCs. Data 
are mean ± s.d. (n=3). ∗ p < 0.05, ∗ ∗ p < 0.01, ∗ ∗ ∗ p < 0.001.  (C) WT and DKO mESCs 
cultured in the absence of feeder layer. (D) Control and 4E-BP1 and 2 double knockdown 
(DKD) mESCs cultured in the absence of feeder layer. (E) and (F) Time-course WB and 
RT-qPCR analysis of expression of selected pluripotency factors in WT and DKO 
mESCs cultured in the absence of feeder layer and LIF for the indicated time. RT-qPCR 
values are normalized to ß-actin. Data are mean ± s.d. (n=3). (G) RT-qPCR analysis of 
selected pluripotency markers in WT and DKO mESCs. Values are normalized to ß-
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actin. Data are mean ± s.d. (n=3). ∗ ∗ p < 0.01, ∗ ∗ ∗ p < 0.001. (H) RT-qPCR analysis of 
WT and DKO embryoid bodies 2 weeks post-differentiation for expression of selected 
differentiation markers. Values are normalized to ß-actin. Data are mean ± s.d. (n=3). 
∗ p < 0.05, ∗ ∗ p < 0.01, ∗ ∗ ∗ p < 0.001, ns= non-significant.  
 
Supplementary Figure 3. Role of YY2 in mESCs and blastocysts formation. (A) RT-
qPCR analysis of Yy2 mRNA expression in WT and DKO mESCs. Values are 
normalized to ß-actin. Data are mean ± s.d. (n=3) ns= non-significant. (B) WT and DKO 
mESCs were transduced with 3 independent shRNAs against Yy2 or control shRNA. 
Resistant colonies were selected with puromycin (5 g/ml) for 2 days and subjected to 
alkaline-phosphatase staining. (C) WB analysis of mESC transduced with 3 independent 
shRNAs against Yy2 or control shRNA. (D) Schematic presentation of CRISPR-Cas9 
target site in mouse Yy2 gene. The guide RNA was specifically designed to avoid regions 
with high homology to mouse Yy1. PAM; the protospacer-adjacent motif. Numbers 
indicate the distance from start codon. (E) The Sequence of the Yy2 alleles in the WT and 
2 mutant male blastocysts depicted in figure 2D. (F) WB analysis of mESC 
overexpressing GFP or v5-YY1. (G) Graphical representation of selected YY2 binding 
peaks, obtained from the UCSC browser. 20 kb windows are displayed.  
 
Supplementary Figure 4. YY1, but not YY2, binds RNA through its N-terminal 
domain. (A) Pairwise alignment of mouse YY1 and YY2 protein sequences using 
Geneious software. The protein motifs are clustered according to their similarity. (B) 
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Purification of triple Flag-tagged (3xF)-YY1 and 3xF-YY2 proteins from 293T cell 
lysate under non-denaturing conditions with anti-Flag M2 Agarose beads and elution 
with 3xFlag-peptide. (C) Coomassie-stained 10% SDS-PAGE gel of purified 3xF-YY1 
and 3xF-YY2 proteins. (D) Prolonged exposure (3 weeks) of the EMSA with radioactive 
labeled single-stranded RNA oligonucleotide probe described in Figure 4E. (E) RNA 
binding prediction at N-terminal domains of YY1 and YY2 using BindN server 
(http://bioinfo.ggc.org/cgi-bin/bindn/bindn.pl). Predicted binding residues are labeled 
with “+” and in red; non-binding residues labeled with “-“ and in green. Numbers denote 
“Confidence” from level 0 (lowest) to level 9 (highest).  
 
Supplementary Figure 5. PTBP1 regulates Yy2 5’UTR intron retention. (A) RT–PCR 
analysis of mESCs, and day 4 (D4) and day 6 (D6) mouse embryoid bodies (mEB) using 
primer pairs designed to recognize the B and ΔB variants (Fw1 and Rv) to estimate the 
splicing efficiency of Yy2 5’ UTR intron; PIR: Percentage of Intron Retention. (B) RT–
PCR analysis (primers Fw1 and Rv) of intron retention in variant B of Yy2 5’UTR in 
different embryonic days or mouse tissues. (C) Consensus PTBP1 or MBNL1 binding 
motifs in 5’UTR of mouse Yy2 mRNA, identified by RBPmap web server. (D) WB 
analysis of PTBP1 expression in mESCs stably expressing two independent shRNAs 
against Ptbp1 or control shRNA (shGFP); related to Figure 5E and S5E. (E) 
Representative images of mESC colonies described in D. (F) and (G) RT-PCR analysis 
of the in vitro splicing products of the A, B and ΔA variants in presence (+) or absence (-
) of the WERI retinoblastoma cell extract. Primers Fw2 and Rv were used in F to 
recognize all 4 possible variants and primers Fw1 and Rv were used in G to recognize B 
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and ΔB variants. (H) Coomassie-stained 10% SDS-PAGE to detect the level of 
recombinant PTBP1 protein used for the in vitro splicing assay in Figures 5F and S5I. 1 
µg of BSA was loaded as control. (I) RT- PCR analysis (primer Fw1 and Rv) of the in 
vitro splicing products in WERI retinoblastoma cell extracts with different amounts of 
recombinant PTBP1 protein. Recombinant BSA was used as a negative control. (J) 
Schematic diagrams of the Renilla (Rluc) and Firefly (Fluc) luciferase reporter mRNA 
constructs used in Figure 5G. (K) Effect of intron retention on sequence/structure of Yy2 
5’ UTR. The mfold web server (http://unafold.rna.albany.edu/?q=mfold/RNA-Folding-
Form) was used to predict the secondary mRNA structures and G. Nucleotides are 
numbered starting from the relevant transcription start site. The intronic sequence is 
highlighted in red. (L) Expression of YY2, PTBP1, and PTBP2 proteins in different 
tissues of a 4-week old female mouse. SE: short exposure, LE: long exposure. 
Supplementary Figure 6. Expression of Ptbp1, Eif4ebp1, and Eif4ebp2 in 
differentiated tissues. Expression profile of Ptbp1, Eif4ebp1, Eif4ebp2, and Sox2 in a 
cohort of embryonic and adult mouse samples.  
 
Supplementary Tables 
Supplementary Table 1: Number of uniquely mapped reads for each mRNA-Seq and 
footprint (RFP) samples (related to Figure 1). 
Supplementary Table 2: Differentially translated mRNAs in DKO vs WT mESCs 
identified by ribosome profiling assay (related to Figure 1). 
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Supplementary Table 3: Differentially expressed mRNAs in DKO vs WT mESCs 
identified by mRNA-Seq assay (related to Figure 1). 
Supplementary Table 4: YY2 ChIP-Seq target peaks in mESCs and the peaks with 
overlap in YY2 and YY1 ChIP-Seq assays (related to Figure 3). 
Supplementary Table 5: List of a cohort of publically available RNA-Seq datasets 
(related to Figure S6). 
Supplementary Table 6: List of primers used in this study. 
 
Supplementary Items:  
Video 1 (Related to Figure 2E): Beating foci in differentiated mESC after induction of 
YY2 expression (0.2 g/ml doxycycline). 
 
Supplementary Materials and Methods 
List of Antibodies, shRNAs and reagents 
Rabbit anti-PTBP1 (Cell Signaling Cat# 8776), rabbit anti-PTBP2 (abcam Cat# 
ab154853), rabbit anti-eIF4G1 (Cell Signaling Cat# 2469), rabbit anti-YY1 (N-terminal; 
Sigma Cat# SAB4200303), mouse anti-YY2 (Santa Cruz Cat# sc-377008), rabbit anti-
4E-BP1 (Cell Signaling Cat# 9644), rabbit anti-4E-BP2 (Cell Signaling Cat# 2845), 
mouse anti-eIF4E (BD Biosciences Cat# 610270), mouse anti-Alpha Tubulin (Santa Cruz 
Cat# sc-23948), mouse anti-β-actin (Sigma Cat# A5441), rabbit anti-NANOG (Bethyl 
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Laboratories Cat# A300-397A), goat anti-OCT-3/4 (Santa Cruz Cat# sc-8628), goat anti-
SOX2 (Y-17), rabbit anti-SOX2 (Cell Signaling Cat# 4195S), mouse anti-c-MYC (Santa 
Cruz Cat# sc-40), mouse anti-Flag (Sigma Cat# F3165), rabbit anti-Phospho-4E-BP1 
Thr37/46 (Cell Signaling Cat#2855), rabbit anti-Phospho-RPS6 (Ser240/244) (Cell 
Signaling Cat#2215), mouse anti-ribosomal protein S6 (C-8), rabbit anti-Caspase-3 (Cell 
Signaling Cat#9665). The following shRNAs were obtained from Sigma Mission library: 
Anti-Ptbp1 shRNA#1; TRCN0000295113, shRNA#2; TRCN0000295168. Anti-Eif4ebp1 
and Eif4ebp2 shRNAs (TRCN0000075612 and TRCN0000075614, respectively).  
 
Generation of inducible shRNA construct 
The “all-in-one” system (Wiederschain et al., 2009) for the inducible expression of 
shRNA against mouse Yy2 (shYy2) was generated by cloning the following oligos into 
Tet-pLKO-puro lentiviral vector: 
mYy2shRNA-T: 
CCGGGGCCAAACCATCGAAGTATATCTCGAGATATACTTCGATGGTTTGGCCT
TTTT 
mYy2shRNA-B: 
AATTAAAAAGGCCAAACCATCGAAGTATATCTCGAGATATACTTCGATGGTT
TGGCC 
Lentiviral particles generated by this vector were used to create stable doxycycline 
inducible shRNA-expressing mESCs.  
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Lentivirus Production 
293FT cells (Invitrogen) were cultured in DMEM/10% FBS medium containing 400 
g/ml neomycin (BioShop) per the manufacturer’s instructions. Medium was replaced by 
antibiotic free medium at least 8 h prior to transfection with Lipofectamine 2000. 10 g 
of expression plasmid, 6.5 g of psPAX2 and 3.5g of pMD2.G packaging plasmids 
were used to transfect 8X106 293FT cells in a 10-cm dish. 24 h post-transfection, the 
medium was collected and replaced with fresh medium. Supernatant was collected for 
additional 2 days, pooled, and subjected to centrifugation in a SW32-Ti rotor at 25,000 
RPM for 1.5 h. The viral pellet was resuspended in DMEM, 10% heat-inactivated FBS 
and rotated overnight at 4°C. The resulting concentrated virus solution was used to infect 
the cells directly in the presence of polybrene (6 g/ml) or stored at  -80°C. 
 
Cap pull-down assay using m7GTP-Sepharose 
7-methyl-GTP (m7GTP)-Sepharose 4B (Jena Biosciences) was incubated with WT or 
DKO mESC lysate (500 ug) in buffer containing 50 mM MOPS/KOH (pH 7.4), 100mM 
KCl, 0.02% NaN3 and 0.5 mM EDTA for 30 min at 4°C and washed five times (5 min 
each) with the same buffer and eluted with 0.2 mM m7GTP for 15 min at 4°C.  Eluted 
proteins were subjected to SDS-PAGE followed by western blotting using the indicated 
antibodies. 
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Analysis of global protein synthesis 
Protein synthesis was measured by [35S]methionine/cysteine metabolic labeling. Briefly, 
mESCs were seeded in a 24-well plate the day before the experiment. Cells were 
incubated in methionine/cysteine-free DMEM supplemented with 10% dialyzed FBS 
(GIBCO) and [35S]methionine/cysteine labeling mixture (10 µCi/ml) at 37°C for 30 min, 
followed by lysis in Laemmli buffer. [35S]methionine/cysteine incorporation was 
determined by trichloroacetic acid (TCA) precipitation followed by scintillation counting. 
 
 
Library preparation and sequencing 
Fragmented mRNAs and RFPs were dephosphorylated using T4 polynucleotide kinase 
(New England Biolabs). Denatured fragments were resuspended in 10 mM Tris (pH 7) 
and quantified using the Bio-Analyzer Small RNA assay (Agilent). A sample of 10 pmol 
of RNA was ligated to the 3′-adaptor with T4 RNA ligase 1 (New England Biolabs) for 2 
h at 37°C. Reverse transcription was carried out using oNTI223 adapter (Illumina) and 
SuperScript III reverse transcriptase (Invitrogen) according to the manufacturer’s 
instructions. Products were separated from the empty adaptor on a 10% polyacrylamide 
Tris/Borate/EDTA-urea (TBE-urea) gel and circularized by CircLigase (Epicentre). 
Ribosomal RNA amounts were reduced by subtractive hybridization using biotinylated 
rDNA complementary oligos (Ingolia et al., 2012). The mRNA and ribosome-footprint 
libraries were amplified by PCR (10 cycles) using indexed primers and quantified using 
the Agilent BioAnalyzer High-Sensitivity assay. DNA was then sequenced on the HiSeq 
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2000 platform with read length of 50 nucleotides (SR50) according to the manufacturer’s 
instructions, with sequencing primer oNTI202 
(5CGACAGGTTCAGAGTTCTACAGTCCGACGATC). 
 
Analysis of Ribosome profiling data 
Reads were trimmed of known adaptor sequences using the FASTX-toolkit. Clipped-
reads shorter than 24 nucleotides were discarded and the remaining reads were aligned 
against mouse rRNA, mtRNA, and tRNA, and unaligned reads were then mapped to the 
mouse genome (mm9) using bowtie2 (local mode) (http://bowtie-
bio.sourceforge.net/bowtie2). Uniquely mapped reads with Mapping Quality (MAPQ) 
score ≥10 were used for further analysis. mRNA translation efficiency within and 
between samples was quantified using the Babel analytical method (Olshen et al. 2013). 
Briefly, a regression-model based approach was used to measure the negative binomial 
distribution to model the abundance of both mRNA and ribosome footprints. Parametric 
bootstrap approach was used to test the null hypothesis that the ribosome footprint-counts 
are similar to mRNA counts. This generated a high-confidence list of genes, whose 
mRNA translation efficiency significantly deviated from global transcript population. We 
used a cut-off of 40-counts for mRNAs to be included in this analysis and Benjamini–
Hochberg method was used to adjust the p-values for multiple comparisons. For 
metagene analysis of read distribution around start or stop codons, reads mapped to 
RefSeq transcripts were used. For a given region, only genes with at least 10 reads whose 
5’ end was within the region were used. The 5’ end position of a read was used for 
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plotting. The read number was normalized within each gene first, and then across all 
genes. The final normalized read number is shown as read number per gene per 
nucleotide.  
 
Analysis of differential mRNA expression 
Differential RNA expression was determined using the mapped mRNA-counts and the 
DESeq method as described (Thomsen et al., 2010). DESeq model count data with 
negative binomial distribution and normalizes read counts based on library size. Genes 
were considered differentially expressed if they exhibited a fold change of >=1.5 and 
FDR<0.05 (based on Benjamini-Hochberg multiple testing adjustment). 
 
5’ rapid amplification of cDNA ends (5′ RACE) analysis 
5′ RACE was performed with the SMARTer RACE 5′/3′ kit (Clontech, Cat # 634858). 
Briefly, 1 µg of total RNA extracted from mESCs was treated with DNase I (Fermentas) 
and cDNA was generated by the SMARTScribe Reverse Transcriptase (Clontech), 
according to the manufacturer's instructions. The resultant cDNA was used for PCR 
amplification using the mouse Yy2 gene-specific forward primers (GSPs) (Suppl. Table 
6) together with a common Universal Reverse Primer (UPM), provided by the 
manufacturer. PCR products were resolved by agarose gel electrophoresis and all visible 
bands were excised and digested by restriction enzymes followed by cloning into the 
PUC19 vector provided by the manufacturer and sequenced by Sanger sequencing. 
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Luciferase reporter with in vitro-transcribed mRNAs  
PCR products encoding the specified 5’UTR variants of Yy2 mRNA followed by Renilla 
luciferase coding sequence were generated, and inserted into pBluescript II KS (+) vector 
(Stratagene) between the SacI and XhoI sites. Resultant plasmids (pBKS-Yy2-5’UTR-A, 
pBKS-Yy2-5’UTR-B, and pBKS-Yy2-5’UTR- ΔA) were used as templates for production 
of the luciferase reporter mRNAs by in vitro transcription using the MAXIscript T7 in 
vitro Transcription kit (Ambion), according to the manufacturer’s protocol in the 
presence of the anti-reverse cap analog. Poly(A) tail was added using the Poly(A) Tailing 
kit (Ambion). WT and DKO mESCs were seeded in a 24-well-plate and cultured 
overnight. The next day cells were transfected with the specified Renilla luciferase 
mRNAs containing Yy2 5’UTRs together with firefly luciferase mRNA, as a transfection 
control, using Lipofectamine 2000 (Invitrogen). Cells were lysed the next day and 
luciferase activity was determined using the Dual-Luciferase Reporter Assay System 
(Promega) according to the manufacturer’s instructions. 
 
RT-PCR assays for detection of Yy2 5’ UTR intron retention 
Poly(A) mRNAs from the indicated mouse tissues or cells were monitored for Yy2 intron 
retention by RT-PCR, as described previously (Barbosa-Morais NL, 2012). Briefly, 0.5 
ng of poly(A)+ RNA was used for cDNA synthesis and amplification with the One-Step 
RT-PCR kit (Qiagen) according to the manufacturer’s recommendations. The number of 
amplification cycles was 24 for Gapdh and 32 for Yy2. Reaction products were resolved 
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using a 2% ethidium bromide agarose gel and imaged using the Gel DocTM XR System 
(Bio-Rad). Gel densitometry was used to calculate the percent of intron retention (PIR), 
measured as the amount of intron retained isoform divided by the sum of spliced and 
retained isoforms. 
 
In vitro splicing assays 
In vitro splicing assays were performed as described (Gueroussov et al., 2015). Briefly, in 
vitro splicing assays (20 µl) contained 1.5 mM ATP, 5 mM creatine phosphate, 5 mM 
DTT, 3 mM MgCl2, 2.6% polyvinyl alcohol (PVA), 30 units of RiboLock RNase 
inhibitor (Fermentas), 10 ng of Yy2 RNA splicing substrate, and 50-60 µg of Weri-Rb1 
cell extract, in 12 µl of lysis buffer (20 mM HEPES pH 7.9, 100 mM KCl, 0.2 mM 
EDTA, 10% glycerol, 1 mM DTT) with or without recombinant proteins (PTBP1 or 
BSA). Transcripts used for in vitro splicing were prepared using Yy2 reporter constructs 
containing a T7 promoter. In vitro transcription was performed using the MEGAscript T7 
Transcription Kit (Life technologies) according to the manufacturer’s recommendations. 
Amount of recombinant protein used: PTBP1: 250, 500, 1000 ng and BSA: 1000 ng. 
Reactions were incubated for 1 h at 30oC. RNA was recovered using TRI Reagent and 
resuspended in 10 µl of nuclease-free water. Intron retention was monitored using 2 µl of 
the recovered RNA in RT-PCR reactions, as described above; “RT-PCR assays for 
detection of Yy2 5’ UTR intron retention”. 
 
Chromatin immunoprecipitation (ChIP) and ChIP-Seq assays 
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Antibodies used for ChIP were anti-RNA Polymerase II (Millipore 05-623), anti-
H3K4Me3 (Millipore 07-473), anti-YY2 (Santa Cruz sc-377008), and anti-mouse IgG 
(ThermoFisher Scientific 10400C). Antibodies were pre-bound overnight at 4°C to 20 µl 
Dynabeads Protein A (ThermoFisher Scientific 10008D) or 20 µl Dynabeads Protein G 
(ThermoFisher Scientific 10004D), diluted in ChIP dilution buffer (1% Triton, 10 mM 
Tris-HCl pH 8, 150 mM NaCl, 2 mM EDTA). For each ChIP assay, chromatin prepared 
from approximately 1 x 107 cells was diluted to 1 ml in ChIP dilution buffer and added to 
the antibody-bound beads. Chromatin was immunoprecipitated overnight with rotation at 
4°C. Beads were washed 5 times at 4°C with wash buffer (50 mM HEPES-KOH pH 7.5, 
1 mM EDTA, 0.7% Sodium Deoxycholate (NaDOC), 1% NP-40, 0.5 M LiCl) and once 
with TE buffer (10 mM Tris-HCl pH 8, 1 mM EDTA). DNA was eluted in 200 µl elution 
buffer (1% SDS, 50 mM Tris-HCl pH 8, 10 mM EDTA) and crosslinks were reversed 
overnight at 65°C, followed by treatment with RNase A (Qiagen 19101) and Proteinase 
K (Roche 03115879001). DNA was purified with the Qiagen PCR Purification Kit 
(Qiagen 28106). Quantification of ChIP enrichment was carried out with SYBR-green-
based qRT-PCR (Roche 04887352001) and the Roche LightCycler instrument. All 
primers used in this study are listed in Suppl. Table 6. 
Sequencing libraries of ChIP DNA and corresponding 10% chromatin inputs were 
prepared at the McGill University and Génome Québec Innovation Centre, following 
quality assessment with the Agilent Bioanalyzer 2100. ChIP libraries were sequenced on 
the Illumina HiSeq 2000 with 50 base-pair reads. Reads from biological replicates were 
combined. 
Bioinformatics analyses of the ChIP-Seq results 
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Sequence trimming and quality filtering was performed with Trimmomatic software 
v.0.32 (Bolger et al., 2014), retaining reads with phred33 score ≥ 30 and length ≥ 50. 
Filtered sequences were aligned to the mm10 assembly with bwa v.0.7.10. Peaks were 
called with the Model-based Analysis of ChIP-Seq (MACS) algorithm v.2.0 (Zhang et 
al., 2008) with p-value 1x10-5 using input reads as control. Peaks were annotated based 
on the nearest TSS with HOMER software v.4.7 (Heinz et al., 2010). Bedgraph files for 
ChIP-Seq visualization was performed with HOMER software and uploaded to the 
UCSC Genome Browser (Kent et al., 2002). For motif enrichment analysis de novo motif 
finding was performed with HOMER software v.4.7 using default parameters. 
Annotation of motif occurrences on ChIP-Seq peaks was performed in a 4 kb window 
from the center of the peak using HOMER software. For Pathway enrichment analysis, 
gene lists were compiled using binding peaks occurring within 20 kb of the TSS of the 
nearest gene. Canonical pathway enrichment analysis was performed on these lists with 
Ingenuity Pathway Analysis (IPA, Ingenuity® Systems, ingenuity.com). P-values to 
identify significantly enriched biological pathways were calculated using Fisher’s exact 
test.  
 
Expression and purification of YY1 and YY2 proteins 
Yy1 and Yy2 ORFs were amplified from mESC cDNA library using the specific primers 
described in Supplementary Table 6 and cloned into the pCDNA5.A-3xF plasmid. 
HEK293H cells (kind gift from Dr. Marcotrigiano) were transfected with the indicated 
plasmid and cells were collected 30 h post-transfection and resuspended in lysis buffer  
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(25 mM HEPES-KOH 7.5, 150 mM NaCl, 0.5% NP40, 5% glycerol, 15 µM ZnCl2, 0.5 
mM DTT, 1 μg/ml RNase A/DNAse I and protease inhibitors) for 10 min on ice. After 
centrifugation, the Flag-tagged proteins were affinity purified using anti-Flag M2 
Agarose beads (Sigma), and eluted with 5x bead volumes of 3xFlag-peptide 0.1mg/mL. 
SYBR gold and Coomassie staining were used to measure protein purification and ensure 
the lack of RNA/DNA impurities. Purified proteins were buffer exchanged to 50 mM 
HEPES-KOH 7.5, 100 mM NaCl, 15 µM ZnCl2, 0.5 mM DTT buffer and concentrated to 
1mM using a 10kDa Amicon (Millipore). Aliquots in 10% glycerol were frozen in liquid 
nitrogen at -80oC for EMSA experiments.  
 
Electrophoretic mobility shifts assay (EMSA) 
Oligonucleotide DNA probe for Arid1a (adopted from Sigova et al,) was generated by 
annealing 30 nt single stranded oligonucleotides (Fw: 5’-
CTCTTCTCTCTTAAAATGGCTGCCTGTCTG-3’, Rv: 5’-
CAGACAGGCAGCCATTTTAAGAGAGAAGAG-3’) to obtain 100 μM stock of 
double stranded DNA probe. 10 pmol were labeled with T4 polynucleotide kinase (PNK, 
Thermo Scientific) and 20 mCi [γ-32P] ATP (Perkin Elmer) for 30 min at 37oC. PNK 
was inactivated at 68oC for 10 min and unincorporated label was removed by 
centrifugation through a spin column (TE-10, Clonthech). The labeling incorporation was 
verified using 1 mL of labeled probe in scintillation liquid. Binding of YY1 and YY2 
proteins to DNA probe was performed according to the Gel-Shift Assay Kit protocol 
(Promega). For each gel shift reaction 3000 cpm of labeled probe was incubated with 
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increasing concentrations of 3xFlag-YY2 or 3xFlag-YY1 proteins (10, 100, 300 nM) 
during 45 min on ice, then 1mL of Flag antibody (Sigma) was added to one sample 
containing 300 nM protein and all samples were incubated for additional 60 min on ice. 
Free DNA-probe and DNA-protein complexes were separated on a 6% DNA retardation 
gel (Novex, Thermo Scientific) at 250V for 25 min in 0.5xTBE at 4oC. Gels were 
vacuum-dried and exposed to an Amersham Hyperfilm (GE Healthcare Life Science) 
with a screen at -80oC. The 30 nt single stranded RNA probe for Arid1 (5’-
rCrUrCrUrUrCrUrCrUrCrUrUrArArArArUrGrGrCrUrGrCrCrUrGrUrCrUrG-3’) 
(adopted from Sigova et al,) was labeled and purified in the same way as the DNA probe. 
EMSAs with the recombinant 3xFlag-YY2 or 3xFlag-YY1 proteins were performed in 
buffer containing 20 mM HEPES-KOH, pH 7.5, 100 mM KCl, 2 mM MgCl2, 15 µM 
ZnCl2, 0.5 mM DTT, 0.05% NP40, 5% glycerol, 0.1mg/ml acetylated BSA (Sigma) and 
SUPERase-In RNase inhibitor (Life Technologies). Increasing amounts of 3xFlag-YY2 
or 3xFlag-YY1 proteins (10, 100, 300, 600 nM) were incubated for 45 min on ice and 
applied to a 6% retardation gel (Novex, Thermo Scientific) at 250V for 25 min in 
0.5xTBE at 4oC. The gels were vacuum-dried and exposed to an Amersham Hyperfilm 
(GE Healthcare Life Science) with a screen at -80oC. 
 
PCR genotyping  
Genomic DNA from the blastocysts was extracted and amplified using primers listed in 
Supplementary Table 6. PCR fragments were then sub-cloned into pGEM-T Easy vector 
for Sanger sequencing. At least 5 clones/outgrowth were sequenced. 
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